Thyroid function in childhood obesity and metabolic comorbidity

Clinica Chimica Acta

Volumn 413, Issue 3-4, 2012, Pages 396-405

  Pacifico, Lucia ^a   Anania, Caterina ^a   Ferraro, Flavia ^a   Andreoli, Gian Marco ^a   Chiesa, Claudio ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b INSTITUTE OF TRANSLATIONAL PHARMACOLOGY   (Italy)

Author keywords

Children; Metabolic syndrome; Nonalcoholic fatty liver disease; Obesity; Thyroid hormones

Indexed keywords

LEPTIN; THYROID HORMONE; THYROTROPIN; THYROTROPIN RECEPTOR;

AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; CHILD; CHILD HEALTH CARE; COMORBIDITY; CONGENITAL HYPOTHYROIDISM; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DYSLIPIDEMIA; ECHOGRAPHY; ENERGY EXPENDITURE; GENE MUTATION; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; THYROID DISEASE; THYROID FUNCTION; THYROID HORMONE BLOOD LEVEL; THYROID HORMONE RESISTANCE; WEIGHT REDUCTION;

ANIMALS; CHILD; COMORBIDITY; HUMANS; METABOLIC DISEASES; OBESITY; THYROID GLAND; THYROID HORMONES; WEIGHT LOSS;

EID: 84455208096     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.11.013     Document Type: Review

References (134)

1. Sokol R.J. The chronic disease of childhood obesity: the sleeping giant has awakened. J Pediatr 2000, 136:711-713.
2. Nathan B.M., Moran A. Metabolic complications of obesity in childhood and adolescence: more than just diabetes. Curr Opin Endocrinol Diabetes Obes 2008, 15:21-29.
3. Rotondi M., Magri F., Chiovato L. Thyroid and obesity: not a one-way interaction. J Clin Endocrinol Metab 2011, 96:344-346.
4. Sorisky A., Bell A., Gagnon A. TSH receptor in adipose cells. Horm Metab Res 2000, 32:468-474.
5. Valyasevi R.W., Harteneck D.A., Dutton C.M., Bahn R.S. Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts. J Clin Endocrinol Metab 2002, 87:2352-2358.
6. Sari R., Balci M.K., Altunbas H., Karayalcin U. The effect of body weight and weight loss on thyroid volume and function in obese women. Clin Endocrinol 2003, 59:258-262.
7. Michalaki M.A., Vagenakis A.G., Leonardou A.S., et al. Thyroid function in humans with morbid obesity. Thyroid 2006, 16:73-78.
8. Bastemir M., Akin F., Alkis E., Kaptanoglu B. Obesity is associated with increased serum TSH level, independent of thyroid function. Swiss Med Wkly 2007, 137:431-434.
9. De Pergola G., Ciampolillo A., Paolotti S., Trerotoli P., Giorgino R. Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. Clin Endocrinol 2007, 67:265-269.
10. Knudsen N., Laurberg P., Rasmussen L.B., et al. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab 2005, 90:4019-4024.
11. Rotondi M., Leporati P., La Manna A., et al. Raised serum TSH levels in patients with morbid obesity: is it enough to diagnose subclinical hypothyroidism?. Eur J Endocrinol 2009, 160:403-408.
12. Rotondi M., Cappelli C., Leporati P., et al. A hypoechoic pattern of the thyroid at ultrasound does not indicate autoimmune thyroid diseases in patients with morbid obesity. Eur J Endocrinol 2010, 163:105-109.
13. Reinehr T. Obesity and thyroid function. Mol Cell Endocrinol 2010, 316:165-171.
14. Reinehr T. Thyroid function in the nutritionally obese child and adolescent. Curr Opin Pediatr 2011, 23:415-420.
15. Stichel H., l'Allemand D., Gruters A. Thyroid function and obesity in children and adolescents. Horm Res 2000, 54:14-19.
16. Reinehr T., Andler W. Thyroid hormones before and after weight loss in obesity. Arch Dis Child 2002, 87:320-323.
17. Reinehr T., de Sousa G., Andler W. Hyperthyrotropinemia in obese children is reversible after weight loss and is not related to lipids. J Clin Endocrinol Metab 2006, 91:3088-3091.
18. Bhowmick S.K., Dasari G., Levens K.L., Rettig K.R. The prevalence of elevated serum thyroid-stimulating hormone in childhood/adolescent obesity and of autoimmune thyroid diseases in a subgroup. J Natl Med Assoc 2007, 99:773-776.
19. Reinehr T., Isa A., de Sousa G., Dieffenbach R., Andler W. Thyroid hormones and their relation to weight status. Horm Res 2008, 70:51-57.
20. Radetti G., Kleon W., Buzi F., et al. Thyroid function and structure are affected in childhood obesity. J Clin Endocrinol Metab 2008, 93:4749-4754.
21. Shalitin S., Yackobovitch-Gavan M., Phillip M. Prevalence of thyroid dysfunction in obese children and adolescents before and after weight reduction and its relation to other metabolic parameters. Horm Res 2009, 71:155-161.
22. Grandone A., Santoro N., Coppola F., Calabró P., Perrone L., Del Giudice E.M. Thyroid function derangement and childhood obesity: an Italian experience. BMC Endocrinol Disord 2010, 10:8.
23. Aeberli I., Jung A., Murer S.B., et al. During rapid weight loss in obese children, reductions in TSH predict improvements in insulin sensitivity independent of changes in body weight or fat. J Clin Endocrinol Metab 2010, 95:5412-5418.
24. Marras V., Casini M.R., Pilia S., et al. Thyroid function in obese children and adolescents. Horm Res Paediatr 2010, 73:193-197.
25. Dekelbab B.H., Abou Ouf H.A., Jain I. Prevalence of elevated thyroid-stimulating hormone levels in obese children and adolescents. Endocr Pract 2010, 16:187-189.
26. Radetti G., Longhi S., Baiocchi M., Cassar W., Buzi F. Changes in life style improve body composition, thyroid function and structure in obese children. J Endocrinol Invest May 27 2011, [Epub ahead of print].
27. Rapa A., Monzani A., Moia S., et al. Subclinical hypothyroidism in children and adolescents: a wide range of clinical, biochemical, and genetic factors involved. J Clin Endocrinol Metab 2009, 94:2414-2420.
28. Légrádi G., Emerson C.H., Ahima R.S., Flier J.S., Lechan R.M. Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology 1997, 138:2569-2576.
29. Nillni E.A., Vaslet C., Harris M., Hollenberg A., BjØrbak C., Flier J.S. Leptin regulates prothyrotropin-releasing hormone biosynthesis. Evidence for direct and indirect pathways. J Biol Chem 2000, 275:36124-36133.
30. Harris M., Aschkenasi C., Elias C.F., et al. Transcriptional regulation of the thyrotropin-releasing hormone gene by leptin and melanocortin signaling. J Clin Invest 2001, 107:111-120.
31. Burman K.D., Latham K.R., Djuh Y.Y., et al. Solubilized nuclear thyroid hormone receptors in circulating human mononuclear cells. J Clin Endocrinol Metab 1980, 51:106-116.
32. Wilms L., Larsen J., Pedersen P.L., Kvetny J. Evidence of mitochondrial dysfunction in obese adolescents. Acta Paediatr 2010, 99:906-911.
33. Reinehr T., Hinney A., de Sousa G., Austrup F., Hebebrand J., Andler W. Definable somatic disorders in overweight children and adolescents. J Pediatr 2007, 150:618-622.
34. Rago T., Chiovato L., Grasso L., Pinchera A., Vitti P. Thyroid ultrasonography as a tool for detecting thyroid autoimmune diseases and predicting thyroid dysfunction in apparently healthy subjects. J Endocrinol Invest 2001, 24:763-769.
35. Kershaw E.E., Flier J.S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004, 89:2548-2556.
36. Fróhbeck G., Gámez-Ambrosi J., Muruzábal F.J., Burrell M.A. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab 2001, 280:E827-E847.
37. Pekary A.E., Levin S.R., Johnson D.G., Berg L., Hershman J.M. Tumor necrosis factor-alpha (TNF-alpha) and transforming growth factor-beta 1 (TGF-beta 1) inhibit the expression and activity of Na+/K(+)-ATPase in FRTL-5 rat thyroid cells. J Interferon Cytokine Res 1997, 17:185-195.
38. Pekary A.E., Hershman J.M. Tumor necrosis factor, ceramide, transforming growth factor-beta1, and aging reduce Na+/I-symporter messenger ribonucleic acid levels in FRTL-5 cells. Endocrinology 1998, 139:703-712.
39. Chrousos G.P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995, 332:1351-1362.
40. Narumi S., Muroya K., Abe Y., et al. TSHR mutations as a cause of congenital hypothyroidism in Japan: a population-based genetic epidemiology study. J Clin Endocrinol Metab 2009, 94:1317-1323.
41. Nicoletti A., Bal M., De Marco G., et al. Thyrotropin-stimulating hormone receptor gene analysis in pediatric patients with non-autoimmune subclinical hypothyroidism. J Clin Endocrinol Metab 2009, 94:4187-4194.
42. Nagasaki K., Narumi S., Asami T., Kikuchi T., Hasegawa T., Uchiyama M. Mutation of a gene for thyroid transcription factor-1 (TITF1) in a patient with clinical features of resistance to thyrotropin. Endocr J 2008, 55:875-878.
43. Arnaud-Lopez L., Usala G., Ceresini G., et al. Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid function. Am J Hum Genet 2008, 82:1270-1280.
44. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
45. Friedman J.M., Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 1998, 395:763-770.
46. Pinkney J.H., Goodrick S.J., Katz J., et al. Leptin and the pituitary-thyroid axis: a comparative study in lean, obese, hypothyroid and hyperthyroid subjects. Clin Endocrinol 1998, 49:583-588.
47. Kozłowska L., Rosołowska-Huszcz D. Leptin, thyrotropin, and thyroid hormones in obese/overweight women before and after two levels of energy deficit. Endocrine 2004, 24:147-153.
48. Iacobellis G., Ribaudo M.C., Zappaterreno A., Iannucci C.V., Leonetti F. Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women. Clin Endocrinol 2005, 62:487-491.
49. Seoane L.M., Carro E., Tovar S., Casanueva F.F., Dieguez C. Regulation of in vivo TSH secretion by leptin. Regul Pept 2000, 92:25-29.
50. Lloyd R.V., Jin L., Tsumanuma I., et al. Leptin and leptin receptor in anterior pituitary function. Pituitary 2001, 4:33-47.
51. Jin L., Burguera B.G., Couce M.E., et al. Leptin and leptin receptor expression in normal and neoplastic human pituitary: evidence of a regulatory role for leptin on pituitary cell proliferation. J Clin Endocrinol Metab 1999, 84:2903-2911.
52. Jin L., Zhang S., Burguera B.G., et al. Leptin and leptin receptor expression in rat and mouse pituitary cells. Endocrinology 2000, 141:333-339.
53. Mantzoros C.S., Ozata M., Negrao A.B., et al. Synchronicity of frequently sampled thyrotropin (TSH) and leptin concentrations in healthy adults and leptin-deficient subjects: evidence for possible partial TSH regulation by leptin in humans. J Clin Endocrinol Metab 2001, 86:3284-3291.
54. Mih́ly E., Fekete C., Tatro J.B., Liposits Z., Stopa E.G., Lechan R.M. Hypophysiotropic thyrotropin-releasing hormone-synthesizing neurons in the human hypothalamus are innervated by neuropeptide Y, agouti-related protein, and alpha-melanocyte-stimulating hormone. J Clin Endocrinol Metab 2000, 85:2596-2603.
55. Rohner-Jeanrenaud F., Jeanrenaud B. The discovery of leptin and its impact in the understanding of obesity. Eur J Endocrinol 1996, 135:649-650.
56. Bell A., Gagnon A., Grunder L., Parikh S.J., Smith T.J., Sorisky A. Functional TSH receptor in human abdominal preadipocytes and orbital fibroblasts. Am J Physiol Cell Physiol 2000, 279:C335-C340.
57. Menendez C., Baldelli R., Camiña J.P., et al. TSH stimulates leptin secretion by a direct effect on adipocytes. J Endocrinol 2003, 176:7-12.
58. Rondinone C.M. Adipocyte-derived hormones, cytokines, and mediators. Endocrine 2006, 29:81-90.
59. Rajala M.W., Scherer P.E. Minireview: the adipocyte- at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 2003, 144:3765-3773.
60. Srinivasan S.R., Myers L., Berenson G.S. Temporal association between obesity and hyperinsulinemia in children, adolescents, and young adults: the Bogalusa Heart Study. Metabolism 1999, 48:928-934.
61. Kvetny J. Nuclear thyroxine receptors and cellular metabolism of thyroxine in obese subjects before and after fasting. Horm Res 1985, 21:60-65.
62. Donders S.H., Pieters G.F., Heevel J.G., Ross H.A., Smals A.G., Kloppenborg P.W. Disparity of thyrotropin (TSH) and prolactin responses to TSH-releasing hormone in obesity. J Clin Endocrinol Metab 1985, 61:56-59.
63. Cornier M.A., Dabelea D., Hernandez T.L., et al. The metabolic syndrome. Endocr Rev 2008, 29:777-822.
64. Ruhla S., Weickert M.O., Arafat A.M., et al. A high normal TSH is associated with the metabolic syndrome. Clin Endocrinol 2010, 72:696-701.
65. Streeten D.H., Anderson G.H., Howland T., Chiang R., Smulyan H. Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension. Hypertension 1988, 11:78-83.
66. Kutty K.M., Bryant D.G., Farid N.R. Serum lipids in hypothyroidism-a re-evaluation. J Clin Endocrinol Metab 1978, 46:55-56.
67. Duntas L.H., Wartofsky L. Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence?. Thyroid 2007, 17:1075-1084.
68. Klein I., Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001, 344:501-509.
69. Hak A.E., Pols H.A., Visser T.J., Drexhage H.A., Hofman A., Witteman J.C. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 2000, 132:270-278.
70. Rodondi N., den Elzen W.P., Bauer D.C., et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 2010, 304:1365-1374.
71. O'Brien T., Dinneen S.F., O'Brien P.C., Palumbo P.J. Hyperlipidemia in patients with primary and secondary hypothyroidism. Mayo Clin Proc 1993, 68:860-866.
72. Biondi B., Cooper D.S. The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008, 29:76-131.
73. Duntas L.H. Thyroid disease and lipids. Thyroid 2002, 12:287-293.
74. Diekman T., Demacker P.N., Kastelein J.J., Stalenhoef A.F., Wiersinga W.M. Increased oxidizability of low-density lipoproteins in hypothyroidism. J Clin Endocrinol Metab 1998, 83:1752-1755.
75. Chait A., Bierman E.L., Albers J.J. Regulatory role of triiodothyronine in the degradation of low density lipoprotein by cultured human skin fibroblasts. J Clin Endocrinol Metab 1979, 48:887-889.
76. Nikkilá E.A., Kekki M. Plasma triglyceride metabolism in thyroid disease. J Clin Invest 1972, 51:2103-2114.
77. Tulloch B.R., Lewis B., Fraser T.R. Triglyceride metabolism in thyroid disease. Lancet 1973, 1:391-394.
78. Danzi S., Klein I. Thyroid hormone and blood pressure regulation. Curr Hypertens Rep 2003, 5:513-520.
79. Ojamaa K., Klemperer J.D., Klein I. Acute effects of thyroid hormone on vascular smooth muscle. Thyroid 1996, 6:505-512.
80. Luboshitzky R., Aviv A., Herer P., Lavie L. Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 2002, 12:421-425.
81. Nagasaki T., Inaba M., Kumeda Y., et al. Increased pulse wave velocity in subclinical hypothyroidism. J Clin Endocrinol Metab 2006, 91:154-158.
82. Parle J.V., Franklyn J.A., Cross K.W., Jones S.R., Sheppard M.C. Circulating lipids and minor abnormalities of thyroid function. Clin Endocrinol 1992, 37:411-414.
83. Bogner U., Arntz H.R., Peters H., Schleusener H. Subclinical hypothyroidism and hyperlipoproteinaemia: indiscriminate l-thyroxine treatment not justified. Acta Endocrinol 1993, 128:202-206.
84. Pirich C., Móllner M., Sinzinger H. Prevalence and relevance of thyroid dysfunction in 1922 cholesterol screening participants. J Clin Epidemiol 2000, 53:623-629.
85. Walsh J.P., Bremner A.P., Bulsara M.K., et al. Thyroid dysfunction and serum lipids: a community-based study. Clin Endocrinol 2005, 63:670-675.
86. Pallas D., Koutras D.A., Adamopoulos P., et al. Increased mean serum thyrotropin in apparently euthyroid hypercholesterolemic patients: does it mean occult hypothyroidism?. J Endocrinol Invest 1991, 14:743-746.
87. Asvold B.O., Vatten L.J., Nilsen T.I., BjØro T. The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur J Endocrinol 2007, 156:181-186.
88. Bakker S.J., ter Maaten J.C., Popp-Snijders C., Slaets J.P., Heine R.J., Gans R.O. The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects. J Clin Endocrinol Metab 2001, 86:1206-1211.
89. Paoli-Valeri M., Guzḿn M., Jiménez-Lápez V., Arias-Ferreira A., Briceño-Ferńndez M., Arata-Bellabarba G. Atherogenic lipid profile in children with subclinical hypothyroidism. An Pediatr 2005, 62:128-134.
90. Zimmermann M.B., Aeberli I., Melse-Boonstra A., et al. Iodine treatment in children with subclinical hypothyroidism due to chronic iodine deficiency decreases thyrotropin and C-peptide concentrations and improves the lipid profile. Thyroid 2009, 19:1099-1104.
91. Kim S.R., Tull E.S., Talbott E.O., Vogt M.T., Kuller L.H. A hypothesis of synergism: the interrelationship of T3 and insulin to disturbances in metabolic homeostasis. Med Hypotheses 2002, 59:660-666.
92. Wennlund A., Felig P., Hagenfeldt L., Wahren J. Hepatic glucose production and splanchnic glucose exchange in hyperthyroidism. J Clin Endocrinol Metab 1986, 62:174-180.
93. Dimitriadis G., Baker B., Marsh H., et al. Effect of thyroid hormone excess on action, secretion, and metabolism of insulin in humans. Am J Physiol 1985, 248(5 Pt 1):E593-E601.
94. Ferńndez-Real J.M., Lápez-Bermejo A., Castro A., Casamitjana R., Ricart W. Thyroid function is intrinsically linked to insulin sensitivity and endothelium-dependent vasodilation in healthy euthyroid subjects. J Clin Endocrinol Metab 2006, 91:3337-3343.
95. Rochon C., Tauveron I., Dejax C., et al. Response of glucose disposal to hyperinsulinaemia in human hypothyroidism and hyperthyroidism. Clin Sci 2003, 104:7-15.
96. Dimitriadis G., Mitrou P., Lambadiari V., et al. Insulin action in adipose tissue and muscle in hypothyroidism. J Clin Endocrinol Metab 2006, 91:4930-4937.
97. Dimitriadis G., Parry-Billings M., Bevan S., et al. The effects of insulin on transport and metabolism of glucose in skeletal muscle from hyperthyroid and hypothyroid rats. Eur J Clin Invest 1997, 27:475-483.
98. Maratou E., Hadjidakis D.J., Kollias A., et al. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol 2009, 160:785-790.
99. Chubb S.A., Davis W.A., Davis T.M. Interactions among thyroid function, insulin sensitivity, and serum lipid concentrations: the Fremantle diabetes study. J Clin Endocrinol Metab 2005, 90:5317-5320.
100. Nader N.S., Bahn R.S., Johnson M.D., Weaver A.L., Singh R., Kumar S. Relationships between thyroid function and lipid status or insulin resistance in a pediatric population. Thyroid 2010, 20:1333-1339.
101. Lonardo A., Carani C., Carulli N., Loria P. 'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis. J Hepatol 2006, 44:1196-1207.
102. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002, 346:1221-1231.
103. Pacifico L., Poggiogalle E., Cantisani V., et al. Pediatric nonalcoholic fatty liver disease: a clinical and laboratory challenge. World J Hepatol 2010, 2:275-288.
104. Kotronen A., Yki-Járvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008, 28:27-38.
105. Pacifico L., Nobili V., Anania C., Verdecchia P., Chiesa C. Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk. World J Gastroenterol 2011, 17:3082-3091.
106. Méndez-Sanchez N., Arrese M., Zamora-Valdés D., Uribe M. Current concepts in the pathogenesis of nonalcoholic fatty liver disease. Liver Int 2007, 27:423-433.
107. Shoelson S.E., Herrero L., Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007, 132:2169-2180.
108. Tilg H., Moschen A.R. Insulin resistance, inflammation, and non-alcoholic fatty liver disease. Trends Endocrinol Metab 2008, 19:371-379.
109. Liangpunsakul S., Chalasani N. Is hypothyroidism a risk factor for non-alcoholic steatohepatitis?. J Clin Gastroenterol 2003, 37:340-343.
110. Pucci E., Chiovato L., Pinchera A. Thyroid and lipid metabolism. Int J Obes Rel Metabol Disord 2000, 24(Suppl. 2):S109-S112.
111. Sanyal A.J., Campbell-Sargent C., Mirshahi F., et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001, 120:1183-1192.
112. Das K., Chainy G.B. Modulation of rat liver mitochondrial antioxidant defence system by thyroid hormone. Biochim Biophys Acta 2001, 1537:1-13.
113. Costantini F., Pierdomenico S.D., De Cesare D., et al. Effect of thyroid function on LDL oxidation. Arterioscler Thromb Vasc Biol 1998, 18:732-737.
114. Vuppalanchi R., Chalasani N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. Hepatology 2009, 49:306-317.
115. Carulli L., Ballestri S., Lonardo A., et al. Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels?. Intern Emerg Med May 11 2011, [Epub ahead of print].
116. Targher G., Montagnana M., Salvagno G., et al. Association between serum TSH, free T4 and serum liver enzyme activities in a large cohort of unselected outpatients. Clin Endocrinol 2008, 68:481-484.
117. Pihlajamáki J., Boes T., Kim E.Y., et al. Thyroid hormone-related regulation of gene expression in human fatty liver. J Clin Endocrinol Metab 2009, 94:3521-3529.
118. Targher G. Visceral adipose tissue may mediate the link between non-alcoholic fatty liver disease and endocrine abnormalities. J Hepatol 2006, 45:454.
119. Lonardo A., Carani C., Carulli N., Loria P. Chicken or egg turned into head or belly. J Hepatol 2006, 45:454-456.
120. Rosenbaum M., Hirsch J., Murphy E., Leibel R.L. Effects of changes in body weight on carbohydrate metabolism, catecholamine excretion, and thyroid function. Am J Clin Nutr 2000, 71:1421-1432.
121. Buscemi S., Verga S., Maneri R., Blunda G., Galluzzo A. Influences of obesity and weight loss on thyroid hormones. A 3-3.5-year follow-up study on obese subjects with surgical bilio-pancreatic by-pass. J Endocrinol Invest 1997, 20:276-281.
122. Alagna S., Cossu M.L., Masala A., et al. Evaluation of serum leptin levels and thyroid function in morbidly obese patients treated with bariatric surgery. Eat Weight Disord 2003, 8:95-99.
123. Moulin de Moraes C.M., Mancini M.C., de Melo M.E., et al. Prevalence of subclinical hypothyroidism in a morbidly obese population and improvement after weight loss induced by Roux-en-Y gastric bypass. Obes Surg 2005, 15:1287-1291.
124. Papavramidis S.T., Zisiadis A.C., Karamouzis M.N., Kessissoglou I.I., Antoniadou H.A., Aidonopoulos A.P. Alterations in thyroid hormones and thyrotropin (TSH) in morbidly obese patients before and after vertical gastroplasty. Obes Surg 1995, 5:298-301.
125. Yashkov Y.I., Vinnitsky L.I., Poroykova M.V., Vorobyova N.T. Some hormonal changes before and after vertical banded gastroplasty for severe obesity. Obes Surg 2000, 10:48-53.
126. Raftopoulos Y., Gagné D.J., Papasavas P., et al. Improvement of hypothyroidism after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg 2004, 14:509-513.
127. Kaptein E.M., Beale E., Chan L.S. Thyroid hormone therapy for obesity and nonthyroidal illnesses: a systematic review. J Clin Endocrinol Metab 2009, 94:3663-3675.
128. Krude H., Biebermann H., Schnabel D., et al. Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10. J Clin Endocrinol Metab 2003, 88:4633-4640.
129. Eliakim A., Barzilai M., Wolach B., Nemet D. Should we treat elevated thyroid stimulating hormone levels in obese children and adolescents?. Int J Pediatr Obes 2006, 1:217-221.
130. August G.P., Caprio S., Fennoy I., et al. Prevention and treatment of pediatric obesity: an endocrine society clinical practice guideline based on expert opinion. J Clin Endocrinol Metab 2008, 93:4576-4599.
131. Carswell J.M., Brown R.S. Thyroid hormone in childhood obesity-no "quick fix" Endocr Pract 2010, 16:157-158.
132. Lazar L., Frumkin R.B., Battat E., Lebenthal Y., Phillip M., Meyerovitch J. Natural history of thyroid function tests over 5years in a large pediatric cohort. J Clin Endocrinol Metab 2009, 94:1678-1682.
133. Laurberg P., Andersen S., Carlé A., Karmisholt J., Knudsen N., Pedersen I.B. The TSH upper reference limit: where are we at?. Nat Rev Endocrinol 2011, 7:232-239.
134. de Moura Souza A., Sichieri R. Association between serum TSH concentration within the normal range and adiposity. Eur J Endocrinol 2011, 165:11-15.